SE7613851L - GLUCOSAMINE DERIVATIVES - Google Patents

GLUCOSAMINE DERIVATIVES

Info

Publication number
SE7613851L
SE7613851L SE7613851A SE7613851A SE7613851L SE 7613851 L SE7613851 L SE 7613851L SE 7613851 A SE7613851 A SE 7613851A SE 7613851 A SE7613851 A SE 7613851A SE 7613851 L SE7613851 L SE 7613851L
Authority
SE
Sweden
Prior art keywords
glucosamine derivatives
increase
glucosamine
derivatives
carboxymethylglucopyranosides
Prior art date
Application number
SE7613851A
Other languages
Swedish (sv)
Other versions
SE445923B (en
Inventor
G Baschang
A Hartmann
J Stanek
A Sele
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SE7613851L publication Critical patent/SE7613851L/en
Publication of SE445923B publication Critical patent/SE445923B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Glucosamine derivatives of the formula <IMAGE> (X, R, R1, R2, R4, R6-R9 have the meaning stated in Claim 1) are prepared by condensation of corresponding 3-O-carboxymethylglucopyranosides with corresponding dipeptides. These glucosamine derivatives have the ability to increase the immunogenicity of an antigen on admixture therewith and, on systemic administration, to enhance the immunological reactivity of the treated organism. They can thus be used as adjuvants to increase the vaccine protection from bacterial, viral or parasitic pathogens.
SE7613851A 1975-12-10 1976-12-09 PROCEDURE FOR PREPARING GLUCOSAMINE DERIVATIVES SE445923B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1604275A CH613709A5 (en) 1975-12-10 1975-12-10 Process for the preparation of glucosamine derivatives

Publications (2)

Publication Number Publication Date
SE7613851L true SE7613851L (en) 1977-06-11
SE445923B SE445923B (en) 1986-07-28

Family

ID=4414012

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7613851A SE445923B (en) 1975-12-10 1976-12-09 PROCEDURE FOR PREPARING GLUCOSAMINE DERIVATIVES

Country Status (30)

Country Link
JP (1) JPS5273820A (en)
AR (2) AR224091A1 (en)
AT (1) AT365607B (en)
AU (1) AU508764B2 (en)
BE (1) BE849214A (en)
CA (1) CA1262400A (en)
CH (2) CH613709A5 (en)
CS (4) CS205026B2 (en)
DD (1) DD129781A5 (en)
DE (1) DE2655500A1 (en)
DK (1) DK154654C (en)
ES (2) ES454118A1 (en)
FI (1) FI64164C (en)
FR (1) FR2361902A1 (en)
GB (1) GB1570625A (en)
GR (1) GR61647B (en)
HK (1) HK32883A (en)
HU (1) HU177970B (en)
IE (1) IE44190B1 (en)
IL (1) IL51076A (en)
MY (1) MY8400123A (en)
NL (1) NL7613666A (en)
NO (1) NO144850C (en)
NZ (1) NZ182837A (en)
PL (4) PL110787B1 (en)
PT (1) PT65946B (en)
SE (1) SE445923B (en)
SG (1) SG11083G (en)
SU (3) SU660589A3 (en)
ZA (1) ZA767333B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
US4370265A (en) * 1974-10-22 1983-01-25 Agence Nationale De Valorisation Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents
GB1571133A (en) * 1976-04-26 1980-07-09 Syntex Inc Immuniological adjuvant peptidoglycans compounds and methods of preparation thereof
DE2862107D1 (en) 1977-12-02 1982-11-18 Takeda Chemical Industries Ltd Glucosamine-peptide derivatives and their pharmaceutical compositions
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
CA1138436A (en) * 1978-02-24 1982-12-28 Gerhard Baschang Process for the manufacture of novel antigens
FR2442241A2 (en) * 1978-03-20 1980-06-20 Anvar NOVEL ESTER COMPOUNDS OF MURAMYL-PEPTIDE, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, IN PARTICULAR IN THE FORM OF LIPOSOMES
FR2420545A1 (en) * 1978-03-20 1979-10-19 Anvar NEW ESTERS OF N-ACETYL-MURAMYL-AMINOACYL-GLUTAMIC ACID OR SUBSTITUTION DERIVATIVES THEREOF WITH ANTI-INFECTIOUS PROPERTIES AND / OR IMMUNOLOGICAL ADJUVANTS
FR2428050A1 (en) * 1978-06-05 1980-01-04 Anvar OLIGOMERS OF MURAMYL-PEPTIDE COMPOUNDS AND DRUGS CONTAINING THEM
FR2428051A1 (en) * 1978-06-05 1980-01-04 Anvar NOVEL MURAMYL-PEPTIDE COMPOUNDS AND MEDICAMENTS CONTAINING THEM
FR2446292A1 (en) * 1979-01-12 1980-08-08 Anvar MURAMYL-PEPTIDES FIXED ON PEPTIDE POLYMERS AND MEDICAMENTS CONTAINING THEM
US4256735A (en) 1979-01-29 1981-03-17 Merck & Co., Inc. Immunologically active dipeptidyl saccharides and methods of preparation
FR2449697A1 (en) 1979-02-20 1980-09-19 Anvar NOVEL MURAMYL-PEPTIDES SUBSTITUTED ON PEPTIDE NITROGEN AND MEDICAMENTS CONTAINING THEM
JPS55111499A (en) * 1979-02-21 1980-08-28 Takeda Chem Ind Ltd Glucosamine derivative and its preparation
JPS5618996A (en) * 1979-06-21 1981-02-23 Dai Ichi Seiyaku Co Ltd Muramyldipeptide derivative
FI75578C (en) 1979-07-25 1988-07-11 Ciba Geigy Ag Analogous procedure for the preparation of pharmacologically acting lipophilic a phosphatidylmuramyl peptides.
JPS5649396A (en) * 1979-09-28 1981-05-02 Dai Ichi Seiyaku Co Ltd Novel muramyldipeptide derivative
EP0026746B1 (en) * 1979-10-02 1985-04-10 Ciba-Geigy Ag Combinatory compositions for use in a method for enhancing the activity of antibiotics, antibiotic preparations having enhanced activity and process for their production
FI803077A (en) 1979-10-12 1981-04-13 Ciba Geigy Ag FOERFARANDE FOER FRAMSTAELLNING AV MYRAMYLPEPTIDER
US4409209A (en) * 1979-10-12 1983-10-11 Ciba-Geigy Corporation Novel phosphorylmuramyl peptides and processes for the manufacture thereof
US4406889A (en) * 1980-02-15 1983-09-27 Ciba-Geigy Corporation Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use
US4368190A (en) * 1980-04-17 1983-01-11 Merck & Co., Inc. Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation
US4310514A (en) 1980-05-05 1982-01-12 Merck & Co., Inc. Immunologically active dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose derivatives and methods of preparation
EP0056560A1 (en) * 1981-01-19 1982-07-28 Ciba-Geigy Ag Active antibiotic compositions, process for their manufacture and process for the antibiotic activity of antibiotics
GR78246B (en) * 1981-01-23 1984-09-26 Ciba Geigy Ag
JPS6042398A (en) * 1983-08-18 1985-03-06 Toshiyuki Hamaoka Muramyldipeptide active ester derivative
EP0541486A1 (en) * 1991-11-07 1993-05-12 Ciba-Geigy Ag Polycyclic conjugates
WO2006118327A1 (en) * 2005-04-27 2006-11-09 Oxygenix Co Ltd Cationic amino acid type lipid
WO2016138286A1 (en) 2015-02-26 2016-09-01 Stc.Unm Irgm and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
US10927147B2 (en) 2015-12-10 2021-02-23 Bharat Biotech International Limited Muramyl peptide derivative compound, synthesis and uses thereof
US10576147B2 (en) * 2015-12-15 2020-03-03 Bharat Biotech International Limited Muramyl peptide derivative compound, synthesis and uses thereof
MX2020002010A (en) 2017-08-21 2020-07-13 Celgene Corp Processes for preparation of (s)-tert-butyl 4,5-diamino-5-oxopent anoate.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186194A (en) * 1973-10-23 1980-01-29 Agence Nationale De Valorisation De La Recherche (Anvar) Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents

Also Published As

Publication number Publication date
AR220686A1 (en) 1980-11-28
FI64164B (en) 1983-06-30
ZA767333B (en) 1977-11-30
DK154654C (en) 1989-05-08
CH613709A5 (en) 1979-10-15
SU747430A3 (en) 1980-07-23
FR2361902B1 (en) 1980-11-07
DK552476A (en) 1977-06-11
IE44190B1 (en) 1981-09-09
CS205028B2 (en) 1981-04-30
SG11083G (en) 1983-09-16
DD129781A5 (en) 1978-02-08
PL110353B1 (en) 1980-07-31
PT65946B (en) 1978-06-14
FR2361902A1 (en) 1978-03-17
PL194291A1 (en) 1978-10-23
MY8400123A (en) 1984-12-31
AT365607B (en) 1982-02-10
NL7613666A (en) 1977-06-14
DE2655500C2 (en) 1988-12-22
FI763541A (en) 1977-06-11
ATA909276A (en) 1981-06-15
PL110787B1 (en) 1980-07-31
ES454118A1 (en) 1978-03-01
NO144850C (en) 1981-11-25
PL110794B1 (en) 1980-07-31
HK32883A (en) 1983-09-02
NZ182837A (en) 1978-07-28
CS205025B2 (en) 1981-04-30
CS205027B2 (en) 1981-04-30
CS205026B2 (en) 1981-04-30
DE2655500A1 (en) 1977-06-23
AR224091A1 (en) 1981-10-30
DK154654B (en) 1988-12-05
IL51076A (en) 1980-09-16
FI64164C (en) 1983-10-10
IE44190L (en) 1977-06-10
CA1262400A (en) 1989-10-17
BE849214A (en) 1977-06-09
JPS638118B2 (en) 1988-02-19
PL112672B1 (en) 1980-10-31
IL51076A0 (en) 1977-02-28
GB1570625A (en) 1980-07-02
GR61647B (en) 1978-12-05
AU508764B2 (en) 1980-04-03
JPS5273820A (en) 1977-06-21
SU660589A3 (en) 1979-04-30
HU177970B (en) 1982-02-28
ES465514A1 (en) 1978-09-16
SE445923B (en) 1986-07-28
AU2042276A (en) 1978-06-15
PT65946A (en) 1977-01-01
SU1060118A3 (en) 1983-12-07
CH614718A5 (en) 1979-12-14
NO144850B (en) 1981-08-17
NO764191L (en) 1977-06-13

Similar Documents

Publication Publication Date Title
SE7613851L (en) GLUCOSAMINE DERIVATIVES
ATE217196T1 (en) UREASE-BASED VACCINE AGAINST HELICOBACTER INFECTIONS
ATE116993T1 (en) SAPONIN REMEDIES.
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
ATE326231T1 (en) MUTATING ENTEROTOXIN AS A NON-TOXIC ORAL ADJUVANT
MX9301706A (en) VACCINE COMPOSITION FOR THE TREATMENT OF HELICOBACTER INFECTION.
DK0541692T3 (en) Herpes simplex virus VP-16 vaccines
SE7511794L (en) FERGEMNE
ES379641A1 (en) Ethylethyleneimine as an inactivation agent
DK313587D0 (en) TETRAHYDROBENZOTHIAZOL COMPOUNDS, THEIR PREPARATION AND USE
GR33644B (en) METHOD FOR THE PREPARATION OF NEW HALOGEN-PLACED TETRAHYDRO-QINAZOLINE.
NO913131L (en) IMMUNOGENIC CONJUGATES OF NON-TOXIC OLIGOSACCHARIDE FROM TABLE TELL PERTUSSIS LIPOOLYSACCHARIDE.
ES446637A1 (en) Acellular vaccines
ATE16348T1 (en) OZONE-INACTIVATED GERMS AS VACCINE.
DE59106398D1 (en) Oligophosphates with an antiviral effect.
JPS51125728A (en) Novel non-medical germicides and their preparation
GB949400A (en) Poliomyelitis vaccines
FR2287912A1 (en) Sepharose type polysaccharides with amino-acid, pref glycine, gps - useful as non-specific immunity adjuvants for vaccines
Umetani Studies on the Vaccine of Rickettsia tsutsugamushi I: Influences of Storage conditions on the Immunogenicity of the Vaccine of Rickettsia tsutsugamushi
SU1739559A1 (en) TREATMENT OF APHTAE EPIZOOTICAE VIRUS TYPE O, USED TO MAKE DIAGNOSTIC SERIES AND ANTIGEN DRUGS
JPS525795A (en) Preparation of tetrahydro pyridopyrimidinone derivatives
GR25079B (en) METHOD FOR THE PREPARATION OF COMPOSITIONS OF THE CARVAZOLIC SERIES.
SU681928A1 (en) ADJUVANT
NO933342L (en) DERIVATIVES OF GP160 AND VACCINES BASED ON GP160 OR A DERIVATIVE THEREOF, CONTAINING AN ADJUVANCE
CA607992A (en) Stable poliomyelitis live virus vaccine

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7613851-0

Effective date: 19940710

Format of ref document f/p: F